NCT07224412 A Digital Intervention to Promote Preschool Nutrition and Activity: The eHEROs Study
| NCT ID | NCT07224412 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cornell University |
| Condition | Health Behavior |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-01-05 |
| Primary Completion | 2027-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-01-05 with a primary completion date of 2027-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this pilot study is to assess the feasibility and acceptability of the Know-How program, a 10-week digital intervention for families of young children promoting healthy eating and activity behaviors and environments.
Eligibility Criteria
Inclusion Criteria: * Participants must have a preschool-aged child (3-5 years) with no disabilities or conditions that impact typical eating and activity behaviors. * Adult participants must have access to a smartphone, reliable internet at home, and can make video calls. Exclusion Criteria: * Adults who do not have a child aged 3-5 or child has a disability/condition that impact typical eating and activity behaviors. * Technology access is limited. * Adults who read, write or speak a language other than English.
Contact & Investigator
Laura L Bellows, PhD
PRINCIPAL INVESTIGATOR
Cornell University
Frequently Asked Questions
Who can join the NCT07224412 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Health Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07224412 currently recruiting?
Yes, NCT07224412 is actively recruiting participants. Contact the research team at laura.bellows@cornell.edu for enrollment information.
Where is the NCT07224412 trial being conducted?
This trial is being conducted at Ithaca, United States.
Who is sponsoring the NCT07224412 clinical trial?
NCT07224412 is sponsored by Cornell University. The principal investigator is Laura L Bellows, PhD at Cornell University. The trial plans to enroll 60 participants.